Company Overview

Development Stage

About the Company

[Summary] A landmark enterprise in the modernization of traditional Chinese medi

Tasly Pharmaceutical Group Co., Ltd. was established in 1994 and is a state-owned pharmaceutical listed company under China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., primarily engaged in drug research and development, production, and sales. It was listed on the Shanghai Stock Exchange on August 23, 2002 (stock code: 600535). Tasly adheres to its positioning in big bio-pharmaceutical technology, offering one-stop, personalized health services to customers and users through a diverse portfolio of modern traditional Chinese medicine, biologics, and chemical drugs. It has developed and cultivated high-quality pharmaceuticals such as Compound Danshen Dripping Pills, Yangxue Qingnao Granules (Pills), Puyouke, and Shuilinjia, while also making forward-looking investments in industries such as cell therapy. In 2025, the company achieved revenue of 8.236 billion yuan and net profit attributable to shareholders of the listed company of 1.105 billion yuan, achieving steady development. It has been listed among the eighth batch of national manufacturing single champion enterprises and the top 100 Chinese pharmaceutical manufacturing enterprises. It has won four national science and technology progress awards, undertaken 16 major national new drug creation projects, and has 14 products with annual sales exceeding 100 million yuan.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Tasly Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 主板
  • Deal: 上交所

Tasly How Fast Is Hiring Growing? (197 open positions)

Manage
Note: How fast is hiring at Tasly Pharmaceutical Group Co., Ltd. growing? Tasly2025: 437 openings (up 37%), 2024: 319 openings (down 11%), 2023: 358 openings (up 95%), 2022: 184 openings (down 64%), 2021: 513 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Tasly Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 267%
  • 2024: Down 88%
  • 2023: Up 4%
  • 2022: Down 11%
Tasly Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Tasly Pharmaceutical Group Co., Ltd. growing? TaslyMaster's recruitment over the years: 2025: 11 openings (up 267%), 2024: 3 openings (down 88%), 2023: 25 openings (up 4%), 2022: 24 openings (down 11%), 2021: 27 openings.

Tasly Doctoral Degree Job Demand Analysis

(More)
+100%
Growth Rate
2026 vs 2025
Tasly Doctoral Hiring by Year: 2026 — 7 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Tasly Pharmaceutical Group Co., Ltd. growing? TaslyDoctorate recruitment over the years: 2026: 14 openings (up 155%), 2025: 7 openings (up 267%), 2023: 23 openings (up 4%), 2022: 12 openings (down 11%), 2021: 10 openings.

Tasly R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Tasly Pharmaceutical Group Co., Ltd.? Based on an analysis of Tasly's job postings over the past year, "医疗卫生/美容保健类" demand: 24.5%, "计算机/网络/技术类": 7.1%, "生物/制药/化工/环保类": 4%, "其他(研发和技术类)": 0.7%, "电气/能源/动力类": 0.7%, "机械/仪器仪表类": 0.4%. For reference only.

Tasly — What Are the Salaries Like? (545 records)

Manage
salary range: 4.5K - 50K, 72.8% of roles pay ¥6-15K
Note: salary statistics are based on 545 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Tasly Pharmaceutical Group Co., Ltd.?Tasly72.8% of positions earn 6-15K, Fresh graduate salary: ¥6.4K。销售类 average salary ¥10.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Tasly

(More)
Are salaries high at Tasly Pharmaceutical Group Co., Ltd.? We provide: 学术代表,医药代表,销售,推广,药学,otc代表,市场,高级专员,ka,运营,临床,学术专员,信息,医学专家,医学经理,开发工程师,财务,分析,java,会计. Click to view detailed salary analysis by job.

Tasly Related Industry Tags

Job Category

  • 销售类
    66% of total 66%
  • 医疗卫生/美容保健类
    25.4% of total 25.4%
  • 市场/公关/媒介类
    10% of total 10%
  • 计算机/网络/技术类
    6.8% of total 6.8%

Education

  • 大专
    57.4% of total 57.4%
  • 本科
    31.3% of total 31.3%
  • 硕士
    6.5% of total 6.5%
  • 博士
    3.7% of total 3.7%

Experience

  • 1-3年
    56.6% of total 56.6%
  • 不限
    23.6% of total 23.6%
  • 3-5年
    9.6% of total 9.6%
  • 5-10年
    9.6% of total 9.6%
View Detailed Analysis

What does Tasly Pharmaceutical Group Co., Ltd. require? Who is Tasly hiring? Tasly recruitment: 销售类占比最多占66%,其次是医疗卫生/美容保健类占25.4%. What education can get in at Tasly? 大专占比最多占57.4%,其次是本科占31.3%. High education required at Tasly? 硕士占6.5%,博士占3.7%. Work experience required at Tasly? 1-3年占比最多占56.6%,其次是不限占23.6%. Where are the job locations at Tasly? 天津占比最多占24.5%,其次是上海占5.8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 149,395.0005万(元)
Legal Representative: 蔡金勇
Date Established:
Credit Code: 9112000023944464XD
Registered Address: 天津市北辰区普济河东道2号(天士力现代中药城)

Partners & Suppliers

国药控股黑龙江有限公司向天士力采购复方丹参滴丸等现代中药 Source
合作客户 医药制造-化学药
供应复方丹参滴丸等中药 Source
合作客户 品牌药企(中药)
老百姓大药房采购天士力生产的中药,如复方丹参滴丸。 Source
合作客户 中药
天士力向重药控股吉林有限公司供应中成药 Source
合作客户 药品生产
采购中药滴丸等生产设备 Source
供应商 中药制药

People who follow Tasly also follow

Tasly Competitors (Similar Companies)

“A leader in the diabetes field”
“Technological innovation and commercial application of pharmaceutical ”
医药 药物研发 健康管理 生物医药
“R&D, production and commercialization of high-quality human vaccines”
“Core corporate philosophy: Harmony between man and nature, benefiting ”
“A listed company focusing on the veterinary drug sector”
大健康 工业 健康产业 制造业
“Comprehensively build the CEEC brand and continuously advance towards ”
“努力把中沃打造成国内甚至国际化的驰名品牌”
新材料 乳胶制品 材料研发 天然橡胶
“Committed to the development of the pharmaceutical industry and human ”
“做好人,做好药”
“Continuously innovating to bring patients medicines that significantly”
“One of the leading enterprises in the pharmaceutical industry”
化工/化学 工程设计 工程总承包/EPC 工程监理

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates